Back to search

Focusmain Ltd

05237719

active
Private Limited Company
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)

Details

C/O MJB AVANTI, OFFICE 12 EPSILON HOUSE, IPSWICH, IP3 9FJ
Incorporated 22/09/2004

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Paul Edward Smith

director · Since 25/10/2004

DIRECTOR

BRITISH · ENGLAND · Age 53

Ms Julie Pateman

director · Since 15/04/2026

IRISH · ENGLAND · Age 51

Persons with Significant Control

Mr Paul Edward Smith

25–50% shares
25–50% votes
Appoint directors
right-to-appoint-and-remove-directors-as-trust
right-to-appoint-and-remove-directors-as-firm
significant-influence-or-control-as-trust
significant-influence-or-control-as-firm

British · England · Age 53

C/O Mjb Avanti, Office 12, Epsilon House, Ipswich, IP3 9FJ

Notified 06/04/2016

Ms Julie Pateman

25–50% shares
25–50% votes

Irish · England · Age 51

C/O Mjb Avanti, Office 12, Epsilon House, Ipswich, IP3 9FJ

Notified 01/04/2025

CompanyRankvs 143+ SIC 72110 peers
71

Financial strength84th percentile among SIC peers · 21/25
Employees66th percentile among SIC peers · 10/15
LiquidityCurrent ratio 4.26× · 20/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
1Charles River U.K. Limited
90
2Werfen Limited
90
3Biopharma Process Systems Limited
90
4Theradex (Europe) Limited
90
5Spicer Consulting Limited
90
6Exmoor Pharma Concepts Limited
90
7Ubc Late Stage (Uk) Limited
90
8Wuxi Apptec Uk Ltd
90
9Cenobiologics Ltd
90
10Ccm Technologies Limited
90
143Focusmain Ltd
81
How is this score calculated?
Financial strength21/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. 2.2. Going Concern Disclosure The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going conc

Key FinancialsYear ending 31/10/2025

Net Worth

£181k

Balance sheet strength

Cash

£196k

Cash in the bank

Net Current Assets

£179k

Working capital

Current Assets

£234k

Current Liabilities

£55k

Fixed Assets

£2k

Debtors

£38k

2avg. employees+1

Tax at Year End

Corp tax£37k
VAT£17k

Director Loans

Company owes directors£64

Balance Sheet

Assets less current liabilities£181k
Signed by Mr Paul Smith 30 July 2026Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied ProfitEst. Revenue
20254.26+£71k£350k
20243.05-£5k£169k
20233.59—£162k

Derived from filed accounts. Not audited figures.